Dyslipidemia in coronavirus disease 2019 pneumonia patients
<p>Coronavirus disease 2019 (COVID-19) pandemic has become a global threat to public health, risk factors of COVID-19 is in urgent need in this fight. We collected data and clinical records from 123 COVID-19 patients at Wuhan Union hospital, China. Of 123 patients enrolled, 6 died in hospital...
Saved in:
Main Authors: | Peng Cao (Author), Sanlan Wu (Author), Tingting Wu (Author), Qilin Zhang (Author), Rui Zhang (Author), Yu Zhang (Author) |
---|---|
Format: | Book |
Published: |
International Journal of Clinical Endocrinology and Metabolism - Peertechz Publications,
2020-11-26.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of the number of coronavirus disease 2019 (COVID-19) vaccination shots on the occurrence of pneumonia, severe pneumonia, and death in SARS-CoV-2-infected patients
by: Shijun Xin, et al.
Published: (2024) -
Clinical and diagnostic importance of dyslipidemia in children and adolescents during the coronavirus disease 2019 pandemic
by: Eun Young Kim
Published: (2022) -
Baseline differences in metabolic profiles of patients with lung squamous cell carcinoma responding or not responding to treatment with nanoparticle albumin-bound paclitaxel (nab-paclitaxel)
by: Peng Cao, et al.
Published: (2023) -
Radiomics Is Effective for Distinguishing Coronavirus Disease 2019 Pneumonia From Influenza Virus Pneumonia
by: Liaoyi Lin, et al.
Published: (2021) -
Acute Kidney Injury in Patients with the Coronavirus Disease 2019: A Multicenter Study
by: Xiaoyang Cui, et al.
Published: (2020)